ESC 2018 Highlights of Late Breaking Trials

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ESC 2018 Highlights of Late Breaking Trials

By Cleveland Clinic Heart, Vascular and Thoracic Institute FEATURING Steven Nissen

30 views

February 5, 2019

Dr. Steven Nissen, Chairman of Cardiovascular Medicine at Cleveland Clinic reviews the results from five ...
read more ↘ clinical trials presented at the European Society of Cardiology Conference which may impact clinical practice: 1) The ATTR-ACT Study (the use of the drug tafamidis in patients who have transthyretin amyloid cardiomyopathy); 2) the ARRIVE and ASCEND studies (the benefits and risks of aspirin use in primary prevention); 3) the AIMS study (impact of irbesartan on rate of aortic dilation in patients with Marfan Syndrome); and last MITRA-FR, (outcomes of MitraClip in patients with functional MR).
↖ read less

0 Comments